Astorg Completes Acquisition of Thermo Fisher Microbiology Business
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
The acquisition will establish the microbiology unit as an independent platform focused on clinical diagnostic consumables and equipment.
New clearances expand MALDI-TOF platform capabilities with improved software, faster sample prep, and broader species coverage.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Avails Medical, a developer of antibiotic susceptibility testing tech, received 510(k) clearance from the U.S. FDA for its new eQUANT system.Â
COPAN Diagnostics' new colony selection software—PhenoMATRIX TAG—automatically chooses isolated colonies on plated media for picking.Â
Hardy Diagnostics released a new Auris Enrichment Broth to detect and identify Candida auris from skin samples.